GlassScriptPhysician profile
Brad Earl Bell
NPI 1275526659
$1,738.14
in general payments reported to CMS, 2019-2025
23 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2021: $295 · 2022: $111 · 2023: $170 · 2024: $238 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $358.70 | 2019-2025 | Lithovue, Rezum Generator |
| Medtronic, INC. | $139.23 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $131.57 | 2019-2025 | Xtandi, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $124.47 | 2019 | |
| Merck Sharp & Dohme LLC | $123.75 | 2019 | |
| Tolmar, INC. | $107.14 | 2024-2025 | Jatenzo, Eligard |
| Axonics, INC. | $92.97 | 2022-2023 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $90.79 | 2023-2025 | Orgovyx, Gemtesa |
| Amgen INC. | $85.00 | 2021 | |
| Abbvie INC. | $75.50 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $72.76 | 2021-2023 | Prolaris |
| Dendreon Pharmaceuticals LLC | $65.84 | 2024-2025 | Provenge |
| Valencia Technologies Corporation | $63.34 | 2024-2025 | Ecoin Device Kit |
| 180 Medical, INC. | $29.89 | 2024 | |
| Allergan, INC. | $26.95 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $25.49 | 2021 | |
| Laborie Medical Technologies Corp. | $21.64 | 2023 | |
| Janssen Biotech, INC. | $20.04 | 2021 | |
| Eisai INC. | $19.00 | 2021 | |
| Progenics Pharmaceuticals, INC. | $18.67 | 2022 | |
| Teleflex LLC | $18.60 | 2022 | |
| Intuitive Surgical, INC. | $13.85 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.